Rapid Micro Biosystems, Inc.RPIDNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR+5.3%
5Y CAGR-42.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+5.3%/yr
Quarterly compound
5Y CAGR
-42.9%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.44% |
| Q3 2025 | -7.11% |
| Q2 2025 | 8.91% |
| Q1 2025 | 8.11% |
| Q4 2024 | -13.74% |
| Q3 2024 | -4.16% |
| Q2 2024 | 6.03% |
| Q1 2024 | 2.41% |
| Q4 2023 | -10.35% |
| Q3 2023 | -2.29% |
| Q2 2023 | 0.00% |
| Q1 2023 | -11.79% |
| Q4 2022 | 1.23% |
| Q3 2022 | 12.45% |
| Q2 2022 | 3.54% |
| Q1 2022 | 4.77% |
| Q4 2021 | 8.89% |
| Q3 2021 | 24.07% |
| Q2 2021 | 23.17% |
| Q1 2021 | 11.03% |
| Q4 2020 | 23.72% |
| Q3 2020 | 25.45% |
| Q2 2020 | -17.15% |
| Q1 2020 | 0.00% |